Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals
  • Print
  • Share
  • E-mail
-
Generic Name: Interferon alfa-2a (recombinant)
Trade Name: Roferon-A
Date Designated: 12/14/1987
Orphan Designation: Treatment of AIDS related Kaposi's sarcoma.
Orphan Designation Status: Designated/Approved
Hoffmann-La Roche, Inc.
340 Kingsland Street
Nutley, New Jersey 07110
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

Marketing approved:

1 Generic Name: Interferon alfa-2a (recombinant)
Trade Name: Roferon-A
Marketing Approval Date: 11/21/1988
Approved Labeled Indication:
Exclusivity End Date: 11/21/1995 
Exclusivity Protected Indication* :  
*Exclusivity Protected Indications are shown for approvals from 01/01/2013 to the present.
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-
-